全文获取类型
收费全文 | 345427篇 |
免费 | 28628篇 |
国内免费 | 12028篇 |
专业分类
耳鼻咽喉 | 2657篇 |
儿科学 | 5366篇 |
妇产科学 | 3668篇 |
基础医学 | 53742篇 |
口腔科学 | 6243篇 |
临床医学 | 29094篇 |
内科学 | 53534篇 |
皮肤病学 | 4271篇 |
神经病学 | 22418篇 |
特种医学 | 7549篇 |
外国民族医学 | 77篇 |
外科学 | 26219篇 |
综合类 | 51659篇 |
现状与发展 | 31篇 |
一般理论 | 31篇 |
预防医学 | 19606篇 |
眼科学 | 6076篇 |
药学 | 46732篇 |
56篇 | |
中国医学 | 16270篇 |
肿瘤学 | 30784篇 |
出版年
2024年 | 499篇 |
2023年 | 5025篇 |
2022年 | 7161篇 |
2021年 | 14746篇 |
2020年 | 11774篇 |
2019年 | 11297篇 |
2018年 | 11011篇 |
2017年 | 10924篇 |
2016年 | 11004篇 |
2015年 | 12107篇 |
2014年 | 18783篇 |
2013年 | 21333篇 |
2012年 | 18437篇 |
2011年 | 21355篇 |
2010年 | 17903篇 |
2009年 | 17997篇 |
2008年 | 17792篇 |
2007年 | 18018篇 |
2006年 | 16424篇 |
2005年 | 15205篇 |
2004年 | 13004篇 |
2003年 | 11714篇 |
2002年 | 9024篇 |
2001年 | 8182篇 |
2000年 | 6852篇 |
1999年 | 6272篇 |
1998年 | 5048篇 |
1997年 | 4576篇 |
1996年 | 4427篇 |
1995年 | 4068篇 |
1994年 | 3646篇 |
1993年 | 3255篇 |
1992年 | 2781篇 |
1991年 | 2460篇 |
1990年 | 2084篇 |
1989年 | 1843篇 |
1988年 | 1763篇 |
1987年 | 1392篇 |
1986年 | 1157篇 |
1985年 | 1872篇 |
1984年 | 2002篇 |
1983年 | 1402篇 |
1982年 | 1520篇 |
1981年 | 1290篇 |
1980年 | 1109篇 |
1979年 | 928篇 |
1978年 | 765篇 |
1977年 | 590篇 |
1976年 | 677篇 |
1975年 | 490篇 |
排序方式: 共有10000条查询结果,搜索用时 62 毫秒
991.
目的总结26例肾下型腹主动脉瘤的手术治疗经验。方法回顾性分析近5年多来手术治疗26例肾下型腹主动脉瘤的临床资料,全组26例,术前均经影像检查证实诊断。行择期手术21例,破裂型腹主动脉瘤急诊手术5例。26例均行腹主动脉瘤切除,人工血管重建术。结果围手术期死亡2例,均为急症手术患者,总病死率7.7%,急诊手术病死率40.0%。随访时间1-5年。术后1,3,5年生存率分别为96%,88%,75%。死亡原因均与腹主动脉瘤和手术无关。结论CTA检查是诊断腹主动脉瘤的可靠方法。手术治疗仍是治疗腹主动脉瘤的重要方法。瘤体直径不是决定手术的唯一指征。影响手术的危险因素主要是高龄、严重的心肺疾病和肾功能不全。 相似文献
992.
MDR1特异性核酶逆转肝癌多药耐药的实验研究 总被引:2,自引:0,他引:2
目的探讨MDR1核酶(N2A+tRNAi^met-iMDRl-sRz,sRz)在裸鼠体内逆转人肝癌组织多药耐药(MDR)的可行性。方法将原发性MDR人肝癌组织裸鼠原位移植模型第2代随机分为A组(空白对照组:生理盐水40μl+Lipofect AMINE^TM2000 10μ1)、B组(阴性对照组:N2A+tRNAi^met 10μg/40μl+Lipofect AMINE^TM2000 10μl)和C组(核酶组:sRz 10μg/40μl+LipofectAMINE^TM2000 10μl),均开腹瘤内注射。瘤内注药1周后用表阿霉素15mg/kg腹腔注射,每周1次,连续4周。彩色B超测量肿瘤体积。化疗结束后1周处死裸鼠,RT-PCR、Western blot法检测肿瘤中MDR1 mRNA及其蛋白P-gp的表达。结果C组每次化疗后肿瘤体积均较前缩小(F=659.99,P〈0.05)。除第1次化疗外,其余各次化疗后C组的抑制率均高于A、B组(F=35.36,12.77,97.60,P〈0.05)。化疗结束后,C组与瘤源以及A、B组相比,肿瘤组织中MDR1 mRNA和P-gp的表达明显降低(F=45.36,3590.40,P〈0.05)。结论sRz可有效降低肝癌细胞表达MDR1 mRNA和P-gp,一定程度上逆转MDR,提高E-ADM的化疗效果。单纯E-ADM化疗可使肝癌组织MDR1 mRNA和P-gp表达升高,诱导MDR的产生。 相似文献
993.
Alcohol is an important risk factor for human oesophageal cancer. There is evidence from epidemiological studies that some
specific alcoholic drinks, e.g. Calvados apple brandy, are associated with a greater risk than others. Alcohol induces cytochrome
P450 2E1 (CYP2E1) and the hypothesis was tested that different alcoholic beverages, containing a variety of alcoholic compounds,
could differentially induce expression of cytochrome P450 enzymes. Twelve groups of five rats each were treated for 3 days
with different alcoholic beverages (ethanol alone, whisky, farm-produced or commercial Calvados brandy, beer, cider, wine)
adjusted to 4, 10 or 20% of ethanol in drinking water. Immunoblotting using a monoclonal antibody specific for rat CYP2E1
revealed a single protein band in liver microsomes. Densitometric quantitation of microsomal proteins demonstrated a significant
two-, three- and sixfold increase in band intensity after treatment with ethanol concentrations of 4, 10 and 20% respectively,
compared to control rats drinking water alone. There was a dose-dependent increase in liver microsomal metabolism of CYP2E1
substrates (para-nitrophenol and dimethylnitrosamine) in ethanol-treated rats. However, there were no significant differences
in the level of CYP2E1 protein or enzymatic activity between the different alcoholic beverages at the same ethanol concentration.
There was a slight increase in hepatic CYP1A-related enzymatic activities in the alcohol-treated rats compared to the controls,
but no difference between the treated groups either with dose of ethanol or type of beverage. These data show that induction
of CYP2E1 with acute alcohol treatment is predominantly determined by the ethanol content of the beverage.
Received: 10 February 1997 / Accepted: 26 May 1997 相似文献
994.
目的:研究脑缺血后脑片[Ca2+]i变化。方法:采用新型Ca2+荧光指示剂Fura-2双波长法测定兔大脑中动脉阻塞(MCAo)局灶脑缺血后脑片细胞内游离钙([Ca2+]i)。结果:脑缺血后脑组织[Ca2+]i显著升高。结论:[Ca2+]i在脑缺血损害中起重要作用。 相似文献
995.
P. V. Luoma A. Rautio J. Steng»rd E. A. Sotaniemi J. Marniemi 《European journal of clinical pharmacology》1990,38(6):625-627
Summary Serum high density lipoprotein (HDL) subfractions HDL2 and HDL3, apolipoproteins, and plasma antipyrine clearance (AP-CL) rate, an index of liver microsomal enzyme activity, were determined in 21 healthy subjects. High HDL cholesterol and HDL2 cholesterol concentrations and HDL cholesterol/cholesterol and HDL2/HDL3 cholesterol ratios were associated with high AP-CL. Phenobarbital enhanced antipyrine elimination and increased the apolipoprotein A-I/A-II ratio. Subjects who had high AP-CL had a more antiatherogenic HDL subfraction and apolipoprotein profile than those with low AP-CL. 相似文献
996.
Y. Tani T. Ishihara T. Kanai T. Ohno J. Andersson A. Lilja G. Antoni K. -J. Fasth P. Bjurling G. Westerberg P. Hartvig H. Onoe Y. Watanabe B. Langström 《Journal of neural transmission (Vienna, Austria : 1996)》1995,102(3):189-208
Summary The effects of 6R-L-erythro-5,6,7,8-tetrahydrobiopterin (R-THBP) on the central cholinergic and dopaminergic systems in the Rhesus monkey brain were investigated by positron emission tomography (PET) with the muscarinic cholinergic receptor ligands (N-[11C]methyl-benztropine) and dopaminergic receptor ligands selective for D1 D2, and D3 subtypes ([11C]SCH23390, N-[11C]methyl-spiperone, and (+)[11C]UH232, respectively). None of the doses (3, 10, and 30 mg/kg i.v.) of R-THBP used significantly affected the regional cerebral blood flow (rCBF as determined by Raichle's H2
15O method), and 10 mg/kg of R-THBP had little effect on the regional cerebral metabolic rate of glucose (rCMRglc) in the Rhesus monkey brain, as assessed by the graphical [18F]fluoro-deoxyglucose method. The effect of R-THBP on the muscarinic cholinergic system was dose dependent; while 3 mg/kg of R-THBP did not significantly alter the uptake ratio of N-[11C]methyl-benztropine in several brain regions to that in the cerebellum, 10 and 30 mg/kg of R-THBP significantly reduced the uptake ratio in the thalamus, as well as in the frontal and temporal cortices. None of the doses (3, 10, and 30 mg/kg i.v.) of R-THBP tested affected [11C]SCH23390 (dopamine D1 receptor) binding. However, the k3 value for N-[11C]methyl-spiperone (dopamine D2 receptor) binding, which represents the association rate × Bmax value, was significantly decreased in the striatum. The uptake ratio of (+)[11C]UH232 (dopamine D3 receptor) in the striatum to that in the cerebellum was also decreased by administration of R-THBP (3 and 30 mg/kg i.v.). These findings suggest that R-THBP acts on dopamine D2 and D3 receptors selectively without markedly affecting dopamine D1 receptor binding. Furthermore, the changes in cholinergic and dopamine D2 and D3 receptors in vivo can not be attributed to a change in rCBF but may depend on the action of R-THBP.Abbreviations
R-THBP
6R-L-erythro-5,6,7,8-tetrahydrobiopterin
-
PET
positron emission tomography
-
rCBF
regional cerebral blood flow
-
rCMRglc
regional cerebral metabolic rate of glucose 相似文献
997.
研究补肾抗衰口服液对大鼠衰老模型免疫器官胸腺和脾脏的影响.结果显示,模型组大鼠胸腺和脾脏重量减轻,胸腺重/体重比值、脾重/体重比值减小,胸腺组织学观察,显示萎缩改变;药物组大鼠胸腺和脾脏重量、胸腺重/体重、脾重/体重比值接近正常对照组,胸腺组织学观察,未显示萎缩改变.本研究结果表明,补肾抗衰口服液能延缓胸腺和脾脏萎缩,保护机体的正常免疫功能,提示该药有抗衰老的作用. 相似文献
998.
用人喉癌手术切除标本建立了裸鼠移植瘤模型,已传至13代。原代移植成功率为66.7%,潜伏期30~70d;鼠间传代移植成功率为100%,潜伏期14~19d,生长稳定。经光学显微镜检查,各代移植瘤组织结构与原人喉癌组织基本一致。电镜检查证明,具有人喉癌特征,癌细胞间有大量桥粒,细胞浆中可见张力原纤维,有的张力原纤维与桥粒相连。细胞表面有较大的指状突,核膜较规则,胞浆中线粒体较多。 相似文献
999.
安徽省农村居民哮喘病现况调查 总被引:3,自引:1,他引:2
本文通过对安徽省农村居民哮喘病的现况调查发现,哮喘病患病率为1.33%,男性为1.48%,女性为1.19%;成人患病率为1.34%,儿童为1.32%。儿童哮喘患病率随年龄增长而下降,而成人哮喘病患病率随年龄增长而增加;儿童大部分婴幼儿起病,各年龄组中男性起病较女性晚,成人女性50%起病20岁前,而男性50%起病30岁前。农村哮喘以感染型为主,发病以冬季多见,发作主要诱因是感冒,哮喘病具有明显家族聚集性。 相似文献
1000.
We attempted to find out the role of α2-adrenoceptors of the medullary lateral reticular nucleus (LRN) in antinociception in rats. Spinal antinociception was evaluated using the tail-flick test, and supraspinal antinociception using the hotplate test. Antinociceptive effects were determined following local electric stimulation of the LRN, and following microinjections of medetomidine (an α2-adrenoceptor agonist; 1–10 μg), atipamezole (an α2-adrenoceptor antagonist; 20 μg) or lidocaine (4%) into the LRN. The experiments were performed using intact and spinalized Hannover-Wistar rats with a unilateral chronic guide cannula. Electric stimulation of the LRN as well as of the periaqueductal gray produced a significant spinal antinociceptive effect in intact rats. Medetomidine (1–10 μg), when microinjected into the LRN, produced no significant antinociceptive effect in the tail-flick test in intact rats. However, following spinalization, medetomidine in the LRN (10 μg) produced a significant atipamezole-reversible antinociceptive effect in the tail-flick test in the hot-plate test, medetomidine (10 μg) in the LRN produced a significant atipamezole-reversible increase of the paw-lick latency in intact rats. Microinjection of atipamezole (20 μg) or lidocaine alone into the LRN produced no significant effects in the tail-flick test. The results are in line with the previous evidence indicating brat the LRN and the adjacent ventrolateral medulla is involved in descending inhibition of spinal nocifensive responses. However, α2-adrenoceptors in the LRN do not mediate spinal antinociception but, on the contrary, their activation counteracts antinociception at the spinal cord level. The spinal aninociceptive effect of supraspinally administered medetomidine in spinalized rats can be explained by a spread of the drug (e.g., via circulation) which then directly activates α2-adrenoceptors at the spinal cord level. 相似文献